PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

NCT00088660 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Pancreatic Cancer

Interventions

BIOLOGICAL: PANVAC™-VF

Sponsor

Therion Biologics Corporation